mTc Lidofenin is a medical term referring to a radiopharmaceutical agent used in diagnostic imaging techniques. It consists of a combination of radioactive technetium-99m (mTc) and Lidofenin, an organic compound with specific affinity for liver cells. The compound is administered intravenously, allowing the radioactive isotope to become distributed throughout the body, where it accumulates primarily in the liver.
This imaging agent is utilized in hepatobiliary scintigraphy, a non-invasive nuclear medicine procedure that helps evaluate the function and structure of the liver, gallbladder, and the biliary system. By tagging Lidofenin with mTc, which emits gamma radiation, it becomes possible to track the movement and activity of this compound within the liver and associated organs. This enables the detection of abnormalities such as blocked bile ducts, gallbladder inflammation, or tumors.
The process of hepatobiliary scintigraphy involves acquiring dynamic images of the liver soon after the administration of mTc Lidofenin and monitoring its uptake, excretion, and clearance. By analyzing the radiotracer's distribution and the rate at which it is eliminated from the liver, healthcare professionals can assess the organ's overall functionality and identify any potential disorders or irregularities.
Overall, mTc Lidofenin provides valuable diagnostic information in liver and biliary system evaluations, aiding in the detection, characterization, and management of various hepatobiliary conditions.
